Eye test may spot Alzheimer's early, study finds

NCT ID NCT07529912

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explored whether a special eye scan (hyperspectral retinal imaging) can detect beta-amyloid, a protein linked to Alzheimer's disease, in the retina. Researchers aimed to see if this non-invasive test could distinguish people with Alzheimer's from healthy individuals. The study included 186 adults aged 30 and older with or without Alzheimer's. The approach could offer a simpler, less invasive way to diagnose Alzheimer's compared to current methods like PET scans.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Centre for Eye Research Australia

    Melbourne, Victoria, 3002, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.